RT Journal Article
SR Electronic
T1 Luteinising hormone releasing hormone for incomplete descent of the testis.
JF Archives of Disease in Childhood
JO Arch Dis Child
FD BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health
SP 568
OP 571
DO 10.1136/adc.60.6.568
VO 60
IS 6
A1 A M Klidjian
A1 P G Swift
A1 J M Johnstone
YR 1985
UL http://adc.bmj.com/content/60/6/568.abstract
AB Forty boys with 54 incompletely descended testes took part in a double blind, controlled trial of intranasal luteinising hormone releasing hormone. In the control (placebo) group of 18 boys there was no significant change in testicular descent and all required orchidopexy; in the 22 treated boys, however, 12 of 29 testes (42%) were found in a lower position. This study supports the idea that a trial of intranasal luteinising hormone releasing hormone (1200 micrograms/day for 28 days) will help clarify the need for orchidopexy in at least 30% of boys with incomplete descent of the testis, particularly those in whom the testes have emerged from the inguinal canal.